News | Cardiovascular Business | May 16, 2022

Boston Scientific Co-founder and Former CEO Passes Away

Boston Scientific announced that Peter M. “Pete” Nicholas, co-founder and former CEO of Boston Scientific from 1979 to 1999 and a corporate visionary in the minimally invasive surgery industry, passed away peacefully on May 14 just a few days before his 81st birthday. 

Pete Nicholas. Image courtesy of Boston Scientific


May 16, 2022 — Boston Scientific announced that Peter M. “Pete” Nicholas, co-founder and former CEO of Boston Scientific from 1979 to 1999 and a corporate visionary in the minimally invasive surgery industry, passed away peacefully on May 14 just a few days before his 81st birthday. 

Boston Scientific Chairman and CEO Mike Mahoney said, “As a pioneer who helped shape the field of minimally invasive surgery, Pete Nicholas is remembered worldwide for his contribution to vastly improved patient outcomes and equally impressive increases in healthcare efficiency.” Mahoney added, “Within the Boston Scientific family, Pete was also a lifelong mentor, motivator and friend to hundreds of employees.”

According to a tribute posted on BostonScientific.com, he was an avid sailor, former lieutenant in the U.S. Navy, and beloved helmsman and career navigator to two generations of his Boston Scientific family of leaders and co-workers. Though he turned over his CEO duties in 1999, Nicholas retained an active role at Boston Scientific as chairman of the board until stepping down in 2016. A dealmaker and entrepreneurial risk-taker, Nicholas and co-founder John Abele built Boston Scientific from a startup with fewer than 50 employees and financed with a $500,000 loan and $300,000 in partners’ capital  into a global industry leader with 27,000 employees and $8.4 billion in revenue in 2016.

For more information: https://www.bostonscientific.com


Additional Content

News | Heart Failure

Oct. 14, 2026 — GLP-1 weight loss drugs known may help protect against heart failure even at doses too low to produce ...

Home October 19, 2026
Home
Feature | Heart Failure | Kyle Hardner

The shift toward steering appropriate cardiovascular cases to outpatient settings is gaining momentum, driven by a ...

Home September 11, 2026
Home
News | Heart Failure

Sept. 9, 2026— Atman Health has been selected by the Advanced Research Projects Agency for Health (ARPA-H) to develop an ...

Home September 11, 2026
Home
News | Heart Failure

Aug. 31, 2026 — A new heart failure (HF) treatment effect calculator could help overcome one of the largest barriers to ...

Home August 31, 2026
Home
News | Heart Failure

July 28, 2026 — Abbott has initiated the Treat TR study, a post-market study of the company’s TriClip transcatheter edge ...

Home July 29, 2026
Home
Subscribe Now